CSRP3 Gene Cardiomyopathy dilated type 1M Genetic Test sale cost 4400 AED
BRAF Gene Cardiofaciocutaneous Syndrome Genetic Test sale cost 4400 AED BRAF Gene Cardiofaciocutaneous Syndrome Genetic Test 5,600 د.إ 4,400 د.إ
DNAJC19 Gene Cardiomyopathy dilated with ataxia Genetic Test sale cost 4400 AED DNAJC19 Gene Cardiomyopathy dilated with ataxia Genetic Test 5,600 د.إ 4,400 د.إ
Sale!

CSRP3 Gene Cardiomyopathy dilated type 1M Genetic Test

4,400 د.إ

-21%

The CSRP3 gene plays a crucial role in the structure and function of the heart muscle. Mutations in the CSRP3 gene are associated with dilated cardiomyopathy type 1M (DCM1M), a genetic disorder that affects the heart’s ability to pump blood efficiently. This condition leads to an enlarged and weakened heart, which can result in heart failure and other complications if not diagnosed and managed properly.

To aid in the diagnosis and management of DCM1M, genetic testing for mutations in the CSRP3 gene is available. This test is crucial for individuals with a family history of dilated cardiomyopathy or those exhibiting symptoms of the condition, as it can confirm the diagnosis and guide treatment options. Furthermore, it can also provide valuable information for family planning and the assessment of risk for family members.

In the UAE, DNA Labs UAE offers the CSRP3 Gene Cardiomyopathy Dilated Type 1M Genetic Test. The cost of the test is 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the CSRP3 gene. The results of this test can provide critical insights into the patient’s condition, enabling personalized treatment plans and helping to improve outcomes for those affected by DCM1M.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CSRP3 Gene Cardiomyopathy dilated type 1M Genetic Test

At DNA Labs UAE, we offer the CSRP3 Gene Cardiomyopathy dilated type 1M Genetic Test. This specific genetic test uses next-generation sequencing (NGS) technology to analyze the CSRP3 gene for mutations associated with dilated cardiomyopathy (DCM).

Test Components

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information

Prior to the CSRP3 Gene Cardiomyopathy dilated type 1M NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with CSRP3 Gene Cardiomyopathy dilated type 1M NGS Genetic DNA Test gene CSRP3.

Test Details

Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormalities in its structure and function. Dilated cardiomyopathy is characterized by the enlargement and weakening of the heart chambers, which can result in heart failure.

The CSRP3 gene provides instructions for producing a protein called cysteine and glycine-rich protein 3. This protein is involved in the organization and function of muscle cells, including those in the heart. Mutations in the CSRP3 gene can disrupt the normal function of the protein, leading to the development of dilated cardiomyopathy.

The NGS genetic test for CSRP3 gene cardiomyopathy, dilated type 1M involves sequencing the DNA of an individual to identify any mutations or variations in the CSRP3 gene that may be associated with the development of dilated cardiomyopathy. This test can help in diagnosing individuals with the condition, as well as identifying individuals who may be at risk of developing the disease.

The test is typically performed using a blood sample or a saliva sample, which is then sent to a laboratory for analysis. The laboratory uses NGS technology to sequence the entire CSRP3 gene and identify any mutations or variations.

The results of the test can help healthcare professionals in determining the appropriate treatment and management strategies for individuals with CSRP3 gene cardiomyopathy, dilated type 1M.

Test Name CSRP3 Gene Cardiomyopathy dilated type 1M Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CSRP3 Gene Cardiomyopathy, dilated type 1M NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CSRP3 Gene Cardiomyopathy, dilated type 1M NGS Genetic DNA Test gene CSRP3
Test Details

CSRP3 gene cardiomyopathy, dilated type 1M is a specific type of genetic test that uses next-generation sequencing (NGS) technology to analyze the CSRP3 gene for mutations associated with dilated cardiomyopathy (DCM).

Cardiomyopathy refers to a group of diseases that affect the heart muscle, leading to abnormalities in its structure and function. Dilated cardiomyopathy is characterized by the enlargement and weakening of the heart chambers, which can result in heart failure.

The CSRP3 gene provides instructions for producing a protein called cysteine and glycine-rich protein 3. This protein is involved in the organization and function of muscle cells, including those in the heart. Mutations in the CSRP3 gene can disrupt the normal function of the protein, leading to the development of dilated cardiomyopathy.

The NGS genetic test for CSRP3 gene cardiomyopathy, dilated type 1M involves sequencing the DNA of an individual to identify any mutations or variations in the CSRP3 gene that may be associated with the development of dilated cardiomyopathy. This test can help in diagnosing individuals with the condition, as well as identifying individuals who may be at risk of developing the disease.

The test is typically performed using a blood sample or a saliva sample, which is then sent to a laboratory for analysis. The laboratory uses NGS technology to sequence the entire CSRP3 gene and identify any mutations or variations. The results of the test can help healthcare professionals in determining the appropriate treatment and management strategies for individuals with CSRP3 gene cardiomyopathy, dilated type 1M.

SKU: TEST-3375 Category:

Related products